Cardiopulmonary exercise testing in heart failure

R Malhotra, K Bakken, E D'Elia, GD Lewis - JACC: Heart Failure, 2016 - jacc.org
Exercise intolerance, indicated by dyspnea and fatigue during exertion, is a cardinal
manifestation of heart failure (HF). Cardiopulmonary exercise testing (CPET) precisely …

Chronotropic incompetence in chronic heart failure: a state-of-the-art review

A Zweerink, ALCJ van der Lingen… - Circulation: Heart …, 2018 - Am Heart Assoc
Chronotropic incompetence (CI) is generally defined as the inability to increase the heart
rate (HR) adequately during exercise to match cardiac output to metabolic demands. In …

Pharmacotherapy for heart failure with reduced ejection fraction and health‐related quality of life: a systematic review and meta‐analysis

RD Turgeon, AR Barry, NM Hawkins… - European Journal of …, 2021 - Wiley Online Library
Aims The aim of this study was to synthesize the evidence on the effect of heart failure with
reduced ejection fraction (HFrEF) pharmacotherapy on health‐related quality of life …

The therapeutic role of ivabradine in heart failure

C Badu-Boateng, R Jennings… - … Advances in Chronic …, 2018 - journals.sagepub.com
Heart failure represents a major global cause of morbidity and mortality. Ivabradine is a
selective funny current (If) inhibitor, which acts on the sinoatrial node, resulting in a reduction …

Selective and Specific Inhibition of I f with Ivabradine for the Treatment of Coronary Artery Disease or Heart Failure

P Deedwania - Drugs, 2013 - Springer
Heart rate is an important contributor in the pathophysiology of both coronary artery disease
(CAD) and heart failure (HF). Ivabradine is an anti-anginal and anti-ischaemic agent, which …

Chronotropic incompetence does not limit exercise capacity in chronic heart failure

HA Jamil, J Gierula, MF Paton, R Byrom… - Journal of the American …, 2016 - jacc.org
Background: Limited heart rate (HR) rise (HRR) during exercise, known as chronotropic
incompetence (CI), is commonly observed in chronic heart failure (CHF). HRR is closely …

Ivabradine for treatment of heart failure

EA Bocchi, VMC Salemi - Expert opinion on drug safety, 2019 - Taylor & Francis
Introduction: Heart failure with reduced ejection fraction (HFrEF) is associated with a worse
outcome. Heart rate (HR) is related to outcome in HFrEF. Ivabradine selectively inhibits If …

Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta‐analysis of randomized controlled trials

S Bryan Richard, B Huang, G Liu, Y Yang… - Clinical …, 2021 - Wiley Online Library
Elevated resting heart rate in chronic heart failure (HF) patients has been associated with
higher mortality and poor prognosis. Ivabradine is a new pure bradycardic agent that has …

Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis

M Maagaard, EE Nielsen, NJ Sethi, N Liang… - BMJ Evidence-Based …, 2022 - ebm.bmj.com
Objectives To assess the beneficial and harmful effects of adding ivabradine to usual care in
participants with heart failure. Design A systematic review with meta-analysis and trial …

Quality of life improvement in older patients with heart failure initiated on ivabradine: results from the UK multi-centre LIVE: LIFE prospective cohort study

D Zachariah, D Stevens, G Sidorowicz… - International journal of …, 2017 - Elsevier
Aims LIVE: LIFE is a multi-centre, open-label, prospective observational cohort study
assessing health-related quality of life (HRQoL) in older patients with chronic heart failure …